Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Update

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 1,276 shares, a drop of 14.2% from the December 31st total of 1,487 shares. Based on an average daily volume of 5,917 shares, the short-interest ratio is presently 0.2 days. Based on an average daily volume of 5,917 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analysts Forecast Growth

CZMWY has been the topic of several recent research reports. Sanford C. Bernstein downgraded Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. The Goldman Sachs Group downgraded Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 20th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Carl Zeiss Meditec presently has a consensus rating of “Hold”.

Carl Zeiss Meditec Stock Down 1.3%

Shares of OTCMKTS CZMWY opened at $32.80 on Tuesday. The business has a 50-day moving average of $45.79 and a two-hundred day moving average of $49.75. Carl Zeiss Meditec has a 1 year low of $32.59 and a 1 year high of $76.28.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.